West Pharmaceutical Services, Inc.WSTNYSE
Loading
Operating Income PerformanceStrong
Percentile Rank79
3Y CAGR-6.8%
5Y CAGR+8.1%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-6.8%/yr
vs +31.6%/yr prior
5Y CAGR
+8.1%/yr
Recent deceleration
Acceleration
-38.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $617.40M | +3.8% |
| 2024 | $594.60M | -16.4% |
| 2023 | $710.90M | -6.9% |
| 2022 | $763.50M | +0.6% |
| 2021 | $758.70M | +81.1% |
| 2020 | $419.00M | +41.0% |
| 2019 | $297.20M | +16.6% |
| 2018 | $254.80M | +10.9% |
| 2017 | $229.70M | +6.6% |
| 2016 | $215.50M | - |